0.916
-0.10 (-10.24%)
| Previous Close | 1.02 |
| Open | 1.02 |
| Volume | 645,934 |
| Avg. Volume (3M) | 1,076,006 |
| Market Cap | 31,634,156 |
| Price / Sales | 0.360 |
| Price / Book | 0.920 |
| 52 Weeks Range | |
| Earnings Date | 16 Apr 2025 |
| Profit Margin | -28.26% |
| Operating Margin (TTM) | -6.08% |
| Diluted EPS (TTM) | -1.09 |
| Quarterly Revenue Growth (YOY) | -6.00% |
| Total Debt/Equity (MRQ) | 49.51% |
| Current Ratio (MRQ) | 1.05 |
| Operating Cash Flow (TTM) | -4.49 M |
| Levered Free Cash Flow (TTM) | -1.94 M |
| Return on Assets (TTM) | -14.90% |
| Return on Equity (TTM) | -50.03% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Distribution (US) | Mixed | Mixed |
| Medical Distribution (Global) | Bullish | Mixed | |
| Stock | Cosmos Health Inc. | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | -4.5 |
| Technical Moving Averages | -3.5 |
| Technical Oscillators | -0.5 |
| Average | -2.13 |
|
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment. |
|
| Sector | Healthcare |
| Industry | Medical Distribution |
| Investment Style | Small Value |
| % Held by Insiders | 31.08% |
| % Held by Institutions | 9.46% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |